Huron appointed Dr. L. Thomas Richards to its Board of Directors, effective July 23, 2026, and named him to the Nominating and Corporate Governance, Finance and Capital Allocation, and Technology and Information Security Committees.
| IndividualDr. L. Thomas Richards | RoleDirector; member of Nominating and Corporate Governance Committee, Finance and Capital Allocation Committee, Technology and Information Security Committee | Type of ChangeAppointed | Effective DateJuly 23, 2026 | ReasonNot disclosed | Replacement InfoNot disclosed | Background DetailsFormer Chair of WittKieffer; prior interim CEO of One BioMed and CEO of TessArae; senior advisor roles; former academic emergency physician; prior M&A banker; holds M.D. (Harvard), M.Phil. (Univ. of Sydney), B.A. (Yale) | Board/Committee Role ChangesAppointed to Nominating and Corporate Governance Committee, Finance and Capital Allocation Committee, Technology and Information Security Committee (all effective July 23, 2026) |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.